Welcome to Dispensed Daily, your daily dose of healthcare news from Business Insider’s healthcare editor Lydia Ramsey Pflanzer and the healthcare team. Subscribe here to get this newsletter in your inbox every weekday.
Hello,
It’s Lydia Ramsey Pflanzer, back in your inbox with the latest developments in healthcare. We’ve made it to September!
In today’s Dispensed: what’s ahead this month in the coronavirus vaccine and treatment race, GoodRx’s top shareholders, and a leaked email reveals CVS told employees not to tell patients if their medications were filled by staffers who had tested positive for COVID-19.
Foto: Source: Steve Parsons-WPA Pool/Getty Images
We could get crucial data on top coronavirus vaccines and treatments in September. Here are the 10 most important events to watch for.
- September could bring crucial data on leading coronavirus vaccines and experimental treatments.
- These events include data from top pharma companies like AstraZeneca, Pfizer, and Regeneron, as well as the start of clinical trials to test a spate of treatments and vaccines.
- Business Insider identified 10 key events that could happen in September in the race for COVID-19 vaccines and drugs.
Read the full story from Andrew Dunn here>>
Foto: GoodRx CEOs Doug Hirsch and Trevor Bezdek Source: GoodRx
GoodRx just filed to go public. Here are the investors and executives that stand to make the most upon its debut.
- On Friday, the prescription-discount startup GoodRx filed to go public in a $100 million initial public offering.
- In the filing, GoodRx disclosed that it has a dual-class stock structure that gives voting rights to some stockholders and not others. The classes of stock will be worth about the same dollar amount upon the startup's public debut.
- Here are the investors that stand to make the most money once GoodRx goes public.
Read the full story from Megan Hernbroth here>>
Leaked email reveals CVS instructed pharmacy staff not to tell patients their medications were filled by someone who tested positive for COVID-19
- A leaked CVS email told staff to not inform patients that their prescriptions were filled by someone who tested positive for COVID-19.
- The Georgia CVS technician who shared the email with Business Insider said the company threatened to discipline or fire staff if they told customers about confirmed COVID-19 cases.
Read the full story from Irene Jiang here>>
More stories we're reading:
- The 22 billion-dollar startups to watch that are revolutionizing healthcare in 2020 (Business Insider)
- The case for speaking quieter and stay masked to avoid coronavirus spread (The Atlantic)
- 12 ways the pandemic has drastically altered fitness and exercise as we know it (Business Insider)
- What Verily's OneFifteen been up to since it got its start about a year ago (Stat News)
See you tomorrow! In the meantime, find me at [email protected].
You can subscribe to this newsletter here.
- Lydia
